documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
14 rows where docket_id = "FDA-2015-D-4750" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 14
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-D-4750-0528 | FDA | None FDA-2015-D-4750 | Stakeholder Meeting Summary APC Final2 | Other | Summary (SUM) | 2023-03-27T04:00:00Z | 2023 | 3 | 2023-03-27T04:00:00Z | 2023-03-27T18:33:47Z | 0 | 0 | 090000648586cdbe | ||
| FDA-2015-D-4750-0527 | FDA | None FDA-2015-D-4750 | APC and OFA - FDA Meeting Summary Memorandum - 11-15-21 | Other | Memorandum | 2023-03-23T04:00:00Z | 2023 | 3 | 2023-03-23T04:00:00Z | 2023-03-23T15:34:38Z | 0 | 0 | 0900006485833052 | ||
| FDA-2015-D-4750-0438 | FDA | None FDA-2015-D-4750 | The ‘‘Deemed To Be a License’’ Provision of the Biologics Price Competition and Innovation Act: Questions and Answers; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-03-05T05:00:00Z | 2020 | 3 | 2020-03-05T05:00:00Z | 2020-03-05T13:45:14Z | 2020-04537 | 0 | 0 | 09000064843ed60b | |
| FDA-2015-D-4750-0439 | FDA | None FDA-2015-D-4750 | The "Deemed To Be a License" Provision of the BPCI Act; Questions and Answers; Guidance for Industry | Other | Guidance | 2020-03-05T05:00:00Z | 2020 | 3 | 2020-03-05T05:00:00Z | 2026-03-02T10:00:13Z | 1 | 0 | 09000064843eda81 | ||
| FDA-2015-D-4750-0026 | FDA | None FDA-2015-D-4750 | Request for Extension from Foley & Lardner LLP | Other | Request for Extension | 2019-02-08T05:00:00Z | 2019 | 2 | 2019-02-08T05:00:00Z | 2019-02-08T21:39:11Z | 0 | 0 | 0900006483a582de | ||
| FDA-2015-D-4750-0027 | FDA | None FDA-2015-D-4750 | Request for Extension from Foley & Lardner, LLP | Other | Request for Extension | 2019-02-08T05:00:00Z | 2019 | 2 | 2019-02-08T05:00:00Z | 2019-02-08T21:56:15Z | 0 | 0 | 0900006483a5830a | ||
| FDA-2015-D-4750-0021 | FDA | None FDA-2015-D-4750 | The ‘‘Deemed to be a License’’ Provision of the BPCI Act: Questions and Answers; Draft Guidance for Industry; Availability; Request for Comments on Preliminary List of Affected Applications | Notice | Notice of Availability | 2018-12-12T05:00:00Z | 2018 | 12 | 2018-12-12T05:00:00Z | 2019-02-12T04:59:59Z | 2024-11-12T22:51:55Z | 2018-26855 | 1 | 0 | 0900006483987c31 |
| FDA-2015-D-4750-0022 | FDA | None FDA-2015-D-4750 | Draft Guidance for Industry The "Deemed to be a License" Provision of the BPCI Act Questions and Answers Guidance for Industry | Other | Guidance | 2018-12-12T05:00:00Z | 2018 | 12 | 2018-12-12T05:00:00Z | 2019-02-12T04:59:59Z | 2024-11-12T22:52:01Z | 1 | 0 | 0900006483988ea0 | |
| FDA-2015-D-4750-0020 | FDA | None FDA-2015-D-4750 | Interpretation of the ‘‘Deemed To Be a License’’ Provision of the Biologics Price Competition and Innovation Act of 2009; Guidance for Industry; Availability | Notice | Notice of Availability | 2018-12-12T05:00:00Z | 2018 | 12 | 2018-12-12T05:00:00Z | 2018-12-12T15:17:09Z | 2018-26854 | 0 | 0 | 0900006483987aea | |
| FDA-2015-D-4750-0023 | FDA | None FDA-2015-D-4750 | 01-Final Guidance for Industry Interpretation of the Deemed to be a License Provision of the Biologics Price Competition and Innovation Act of 2009 | Other | Guidance | 2018-12-12T05:00:00Z | 2018 | 12 | 2018-12-12T05:00:00Z | 2024-11-12T22:53:33Z | 1 | 0 | 0900006483988e9e | ||
| FDA-2015-D-4750-0019 | FDA | None FDA-2015-D-4750 | Memorandum of Meeting with Mylan | Other | Memorandum | 2018-08-31T04:00:00Z | 2018 | 8 | 2018-08-31T04:00:00Z | 2018-08-31T16:17:36Z | 0 | 0 | 09000064836875b1 | ||
| FDA-2015-D-4750-0012 | FDA | None FDA-2015-D-4750 | Attachment 1 Draft Guidance " Implementation of the ''Deemed to be a License'' Provision of the Biologics Price Competition and Innovation Act of 2009" re: Comment from Biotechnology Innovation Organization | Supporting & Related Material | Background Material | 2016-06-07T04:00:00Z | 2016 | 6 | 2016-06-07T14:02:24Z | 0 | 0 | 0900006482018d24 | |||
| FDA-2015-D-4750-0001 | FDA | None FDA-2015-D-4750 | Implementation of the ‘‘Deemed To Be a License’’ Provision of the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability and Request for Comments | Notice | Notice of Availability | 2016-03-14T04:00:00Z | 2016 | 3 | 2016-03-14T04:00:00Z | 2016-05-14T03:59:59Z | 2016-05-14T04:00:39Z | 2016-05626 | 0 | 0 | 0900006481ebf885 |
| FDA-2015-D-4750-0002 | FDA | None FDA-2015-D-4750 | Draft Guidance for Industry: Implementation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009 | Other | Guidance | 2016-03-14T04:00:00Z | 2016 | 3 | 2016-03-14T04:00:00Z | 2024-11-12T05:56:21Z | 1 | 0 | 0900006481ebffbd |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;